FDA DEVICE FACTS
Esthetic Colorant
Kuraray Noritake Dental, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Esthetic Colorant is used for coloring pre-sintered zirconia structures for the fabrication of all-ceramic restorations. Zirkonzahn COLOUR LIQUID is used for coloring pre-sintered zirconia structures. Similar Technology Aqueous solutions of transition and lanthanoid metal salts. Aqueous solutions of transition and lanthanoid metal salts. Similar Chemical composition A solvent consisting mostly of water. A solute consisting of transition and lanthanoid metal salts. Other chemical ingredients. A solvent consisting mostly of water. A solute consisting of transition and lanthanoid metal salts. Minor difference (Note 5-8-1.) Operating principle Brush zirconia ceramic structures with coloring liquid before sintering Brush or immerse zirconia ceramic structures with coloring liquid before sintering Similar Type of packaging and volume Bottle; 12 ml Bottle; 20 ml, 50 ml, 100 ml Similar Shade Various Various Similar Storage conditions Max: 30°C, 2 years Max: 25°C, 5 years Minor difference (Note 5-8-2.) Sterile Non-sterile Non-sterile Same Biocompatibility Established (the worst case biocompatibility with ISO 10993-1:2018) Established (the worst case biocompatibility with ISO 10993-1:2010). Similar (Note 5-8-3.)
8-1. Discussion of chemical composition The subject device and the predicate device are the same in that they are aqueous solutions of transition metal salts and lanthanoid metal salts. As the subject device contains other chemical ingredients, we evaluated the biocompatibility of the subject de vice in combination with 510(k) cleared dental zirconia and confirmed that these differences of chemical composition did not affect the biological safety of the subject device.
8-2. Discussion of storage conditions In order to establish the storage conditions of the subject device, the test sample was accelerated and deteriorated and the requirements of ISO 6872:2015 was evaluated, and it was confirmed that there was no problem.
8-3. Established of biocompatibility Biocompatibility was evaluated using the same ISO 10993 -1 as the predicate device. Biocompatibility test was evaluated on the worst case model of the subject device as in the predicate device, and it was confirmed that the subject device satisfied biocompatibility.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。